article

Screening In-Depth Focus 2017

Posted: 5 June 2017 | | No comments yet

Included in this Screening In-Depth Focus: Phenotypic and target-based screening; Killing cancer cells using clinical drug resistance; Inflammatory biomarkers as a herbal anti-arthritic drug discovery tool…

Screening in-depth focus digital issue #2 2017
  • Phenotypic and target-based screening – complementary or competing?
    Sheraz Gul, Fraunhofer-IME SP
  • Using clinical drug resistance to kill cancer cells
    Howard Fearnhead, NUI Galway and Sheraz Gul, Fraunhofer-IME SP
  • Inflammatory biomarkers as a herbal anti-arthritic drug discovery tool
    Mahfoozur Rahman, Sam Higginbottom University of Agriculture, Technology & Sciences; Sarwar Beg, University Institute of Pharmaceutical Sciences; Imran Kazmi, Glocal School of Pharmacy; Amita Verma, Shalom Institute of Health and Allied sciences; Firoz Anwar, King Abdulaziz University; Vikas Kumar, Shalom Institute of Health and Allied sciences

This Screening In-Depth Focus is restricted to logged-in members. Login or become a member now (it's free!) to read it.


Send this to a friend